Reaction Details | |||
---|---|---|---|
Report a problem with these data | |||
Target | Major prion protein | ||
Ligand | BDBM357274 | ||
Substrate/Competitor | n/a | ||
Meas. Tech. | Human Platelet Aggregation Inhibition Test | ||
IC50 | 220±n/a nM | ||
Citation | Tran, T; Ibarra, JB; Shin, Y; Ullman, B; Zou, N; Zeng, X Pyrazolyl substituted carbonic acid derivatives as modulators of the prostacyclin (PGI2) receptor useful for the treatment of disorders related thereto US Patent US10214518 Publication Date 2/26/2019 | ||
More Info.: | Get all data from this article, Assay Method | ||
Major prion protein | |||
Name: | Major prion protein | ||
Synonyms: | ALTPRP | ASCR | CD_antigen=CD230 | PRIO_HUMAN | PRIP | PRNP | PRP | PrP27-30 | PrP33-35C | Prion protein | major prion protein preproprotein | ||
Type: | PROTEIN | ||
Mol. Mass.: | 27671.97 | ||
Organism: | Homo sapiens (Human) | ||
Description: | ChEMBL_158887 | ||
Residue: | 253 | ||
Sequence: |
| ||
BDBM357274 | |||
n/a | |||
Name | BDBM357274 | ||
Synonyms: | 2-(((1s,4s)-4-((4-(5- fluoropyridin-3-yl)-5- (methylthio)-3-phenyl-1H- pyrazol-1- yl)methyl)cyclohexyl) methoxy)acetic acid | US10214518, Compound 135 | ||
Type | Small organic molecule | ||
Emp. Form. | C25H28FN3O3S | ||
Mol. Mass. | 469.572 | ||
SMILES | CSc1c(c(nn1C[C@@H]1CC[C@H](COCC(O)=O)CC1)-c1ccccc1)-c1cncc(F)c1 |r,wU:8.8,11.12,(-2.88,4.75,;-3.97,3.66,;-3.57,2.18,;-4.65,1.08,;-3.94,-.29,;-2.42,-.04,;-2.2,1.49,;-.86,2.26,;.47,1.49,;.47,-.05,;1.8,-.82,;3.14,-.05,;4.47,-.82,;5.81,-.05,;7.14,-.82,;8.47,-.05,;9.81,-.82,;8.47,1.49,;3.14,1.49,;1.8,2.26,;-4.34,-1.78,;-5.83,-2.18,;-6.23,-3.66,;-5.14,-4.75,;-3.65,-4.35,;-3.25,-2.87,;-6.14,1.48,;-6.54,2.96,;-8.03,3.36,;-9.12,2.27,;-8.72,.79,;-9.81,-.3,;-7.23,.39,)| | ||
Structure |